
Exelixis Inc (EXEL) Dividend History
Exelixis Inc (EXEL) is a biotechnology company focused on developing and commercializing innovative therapies for cancer. Founded in 1994, the company has developed a portfolio of targeted treatments, including cabozantinib, which is used for the treatment of multiple types of cancer such as kidney, liver, and thyroid cancers. Exelixis emphasizes research in oncology and aims to advance therapies that improve patient outcomes.
Dividend History
Exelixis Inc currently does not pay dividends
Company News
-
The Motley Fool
-
The Motley Fool